Detalhe da pesquisa
1.
Modulation Effects of the CEP128 Gene on Radiotherapy-Related Brain Injury: A Longitudinal Structural Study Using Multi-Parametric Brain MR Images.
J Magn Reson Imaging
; 59(2): 648-658, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37249021
2.
Concurrent chemoradiotherapy followed by adjuvant cisplatin-gemcitabine versus cisplatin-fluorouracil chemotherapy for N2-3 nasopharyngeal carcinoma: a multicentre, open-label, randomised, controlled, phase 3 trial.
Lancet Oncol
; 24(7): 798-810, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37290468
3.
Anlotinib as a third-line or further treatment for recurrent or metastatic nasopharyngeal carcinoma: a single-arm, phase 2 clinical trial.
BMC Med
; 21(1): 423, 2023 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37936166
4.
The efficacy and safety of apatinib plus capecitabine in platinum-refractory metastatic and/or recurrent nasopharyngeal carcinoma: a prospective, phase II trial.
BMC Med
; 21(1): 94, 2023 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-36927541
5.
Radiomic signatures reveal multiscale intratumor heterogeneity associated with tissue tolerance and survival in re-irradiated nasopharyngeal carcinoma: a multicenter study.
BMC Med
; 21(1): 464, 2023 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38012705
6.
Head and neck MRI-based T stage and [18F]FDG PET/CT-based N/M stage improved prognostic stratification in primary nasopharyngeal carcinoma.
Eur Radiol
; 33(11): 7952-7966, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37314471
7.
Deep learning signatures reveal multiscale intratumor heterogeneity associated with biological functions and survival in recurrent nasopharyngeal carcinoma.
Eur J Nucl Med Mol Imaging
; 49(8): 2972-2982, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35471254
8.
Identifying optimal candidates for postoperative adjuvant therapy among regional persistent/recurrent nasopharyngeal carcinoma patients after neck dissection.
BMC Cancer
; 22(1): 1129, 2022 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36329397
9.
Prognostic significance of AKR1C4 and the advantage of combining EBV DNA to stratify patients at high risk of locoregional recurrence of nasopharyngeal carcinoma.
BMC Cancer
; 22(1): 880, 2022 Aug 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35953777
10.
Nomogram for the prediction of primary distant metastasis of nasopharyngeal carcinoma to guide individualized application of FDG PET/CT.
Eur J Nucl Med Mol Imaging
; 48(8): 2586-2598, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33420610
11.
Subdivision of de-novo metastatic nasopharyngeal carcinoma based on tumor burden and pretreatment EBV DNA for therapeutic guidance of locoregional radiotherapy.
BMC Cancer
; 21(1): 534, 2021 May 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33975558
12.
Percent change in apparent diffusion coefficient and plasma EBV DNA after induction chemotherapy identifies distinct prognostic response phenotypes in advanced nasopharyngeal carcinoma.
BMC Cancer
; 21(1): 1320, 2021 Dec 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34886807
13.
Low value of whole-body dual-modality [18f]fluorodeoxyglucose positron emission tomography/computed tomography in primary staging of stage I-II nasopharyngeal carcinoma: a nest case-control study.
Eur Radiol
; 31(7): 5222-5233, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33416977
14.
Construction of a comprehensive nutritional index and comparison of its prognostic performance with the PNI and NRI for survival in older patients with nasopharyngeal carcinoma: a retrospective study.
Support Care Cancer
; 29(9): 5371-5381, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-33686519
15.
Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein-Barr virus DNA level.
BMC Cancer
; 20(1): 89, 2020 Feb 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32013967
16.
Relationship of circulating tumor cells and Epstein-Barr virus DNA to progression-free survival and overall survival in metastatic nasopharyngeal carcinoma patients.
Int J Cancer
; 145(10): 2873-2883, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31044420
17.
Maximal standard uptake values of 18F-fluoro-2-deoxy-D-glucose positron emission tomography compared with Epstein-Barr virus DNA as prognostic indicators in de novo metastatic nasopharyngeal carcinoma patients.
BMC Cancer
; 19(1): 908, 2019 Sep 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31511059
18.
Identifying optimal candidates for local treatment of the primary tumor among patients with de novo metastatic nasopharyngeal carcinoma: a retrospective cohort study based on Epstein-Barr virus DNA level and tumor response to palliative chemotherapy.
BMC Cancer
; 19(1): 92, 2019 Jan 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30665378
19.
Neoadjuvant or Adjuvant Chemotherapy Plus Concurrent CRT Versus Concurrent CRT Alone in the Treatment of Nasopharyngeal Carcinoma: A Study Based on EBV DNA.
J Natl Compr Canc Netw
; 17(6): 703-710, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31200353
20.
Efficacy of controlled-release oxycodone for reducing pain due to oral mucositis in nasopharyngeal carcinoma patients treated with concurrent chemoradiotherapy: a prospective clinical trial.
Support Care Cancer
; 27(10): 3759-3767, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30712098